Skip to search formSkip to main contentSkip to account menu

Lopinavir:MCnc:Pt:Ser/Plas:Qn

Known as: lopinavir:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo, Lopinavir:MCnc:Pt:Siero/Plasma:Qn, Lopinavir [Masse/Volume] Sérum/Plasma ; Numérique 
National Institutes of Health

Related topics

Related topics

4 relations
PlasSerumUnit of Mass Concentrationlopinavir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Neunte Retrovirus-Konferenz in Seattle, 24.–28. Februar 2002
  • U. Marcus
  • Bundesgesundheitsblatt - Gesundheitsforschung…
  • 2014
  • Corpus ID: 42931122
Noch immer hinken die Informationen zur Pharmakokinetik von Kombinationstherapien in der Schwangerschaft denen anderer… 
2012
2012
Efficacy and safety of switching double‐boosted protease inhibitors to boosted darunavir in HIV‐infected patients with virologic suppression
Switching to ritonavir‐boosted darunavir (DRV/r) in patients treated with double ritonavir‐boosted protease inhibitors (PI/r) may… 
2012
2012
Long‐term durability of nevirapine‐based ART in a cohort of 82 patients after induction with protease inhibitor treatment
There is still an open question how to start antiretro‐viral therapy (ART). This retrospective study shows results of a de… 
2011
2011
Simplificación a monoterapia con lopinavir/ritonavir en niños infectados por el virus de la inmunodeficiencia humana
2005
2005
Steady-State Pharmacokinetics and Tolerability of Indinavir-Lopinavir/R Combination Therapy in Antiretroviral-Experienced Patients
Six HIV-positive antiretroviral experienced patients initiating therapy with a regimen including lopinavir/ritonavir (400/100 mg… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)